Pathstone Family Office’s Progyny PGNY Stock Holding History

Pathstone Family Office’s Portfolio PGNY Stock Details PGNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-470	Closed	-$14K	–	1291
2020 Q3	$14K	Buy	+470	New	+$13K	﹤0.01%	549

Other funds holding PGNY

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

KXA

KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Pathstone Family Office's PGNY Position: Q4 2020 in Review

Pathstone Family Office sold out of Progyny (PGNY) in Q4 2020, closing a stake of 470 shares — an estimated $14K sold.

Pathstone Family Office first reported a position in PGNY in Q3 2020 and held it in 1 quarter. The position peaked at $14K in Q3 2020. 187 funds tracked by Wall St. Rank hold PGNY as of Q4 2020.

Pathstone Family Office reported no remaining Progyny position as of Q4 2020 after selling out during the quarter.
Pathstone Family Office sold 470 Progyny shares in Q4 2020, an estimated $14K.
Pathstone Family Office first reported a position in Progyny in Q3 2020 and held it in 1 quarter.
Pathstone Family Office's Progyny position peaked at $14K in Q3 2020.
187 funds tracked by Wall St. Rank held Progyny as of Q4 2020.

Based on Pathstone Family Office's 13F filing for Q4 2020, filed 16 Feb 2021.